Model Medicines

Model Medicines is a privately held company based in La Jolla, California. The company employs 16 individuals and has generated $2.5 million in revenue. Model Medicines is an AI-driven, human health company focused on leveraging artificial intelligence to model chemistry and human biology. This approach accelerates the development of innovative drugs designed to address a wide range of health challenges. They boast a substantial portfolio of over 182 compounds targeting 26 different therapeutic areas. The company's key differentiator is its innovative use of AI to model all of chemistry and human biology. This proprietary technology aims to streamline and accelerate the drug discovery process, potentially leading to faster development and availability of groundbreaking treatments. Model Medicines is currently developing a pipeline of patent-pending therapeutics for oncology, infectious diseases, gastric disorders, neurological disorders, and weight disorders. To learn more about Model Medicines' groundbreaking work in AI-driven drug discovery, visit their website at modelmedicines.com.